Clinical Manual of Geriatric Psychopharmacology. Sandra A. Jacobson (2014) Washington, DC: American Psychiatric Publishing. Second Edition. 536 PP
Clinical Manual of Geriatric Psychopharmacology. Sandra A. Jacobson (2014) Washington, DC: American Psychiatric Publishing. Second Edition. 536 PP
Clinical Manual of Geriatric interactions, protein binding, metabolism, as neurocognitive disorders due to neurodegen-
well as clearance in both the kidney and the erative disorders such as Alzheimer's and
Psychopharmacology. liver are described. Medical considerations Parkinson's disease. It addresses not only cog-
and instructions for drug prescribing practices nitive enhancing treatment but also the role
Sandra A. Jacobson (2014) are included and are particularly relevant for of these drugs in managing agitation and
Washington, DC: those medically compromised older patients other behavioral symptoms of these dementing
seen in clinical practices. A fairly compre- illnesses.
American Psychiatric hensive list of medications to be avoided in Throughout the text, there are highlighted
Publishing. Second select geriatric patient populations due to po- boxes that share brief, clinically relevant facts
tential complications is also presented. This that will aid the clinician in formulating their
Edition. 536 pp. table clearly delineates the rationale why they treatment plans. All chapters can be used as a
should be avoided, as well as the strength of quick reference for specific drugs use or clini-
330 www.jonmd.com The Journal of Nervous and Mental Disease • Volume 204, Number 4, April 2016